Cargando…

Prediction of nocturnal hypoglycemia unawareness by fasting glucose levels or post-breakfast glucose fluctuations in patients with type 1 diabetes receiving insulin degludec: A pilot study

OBJECTIVE: To evaluate whether nocturnal asymptomatic hypoglycemia (NAH) can be predicted by fasting glucose levels or post-breakfast glucose fluctuations in patients with type 1 diabetes (T1D) receiving insulin degludec. METHODS: Patients with T1D receiving insulin degludec underwent at-home CGM as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi, Hiroshi, Nishimura, Rimei, Onda, Yoshiko, Ando, Kiyotaka, Tsujino, Daisuke, Utsunomiya, Kazunori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499999/ https://www.ncbi.nlm.nih.gov/pubmed/28683068 http://dx.doi.org/10.1371/journal.pone.0177283

Ejemplares similares

Can Fasting Glucose Levels or Post-Breakfast Glucose Fluctuations Predict the Occurrence of Nocturnal Asymptomatic Hypoglycemia in Type 1 Diabetic Patients Receiving Basal-Bolus Insulin Therapy with Long-Acting Insulin?
por: Mitsuishi, Sumie, et al.
Publicado: (2015)

The relationship between HbA1c values and the occurrence of hypoglycemia as assessed by continuous glucose monitoring in patients with type 1 diabetes
por: Tsujino, Daisuke, et al.
Publicado: (2016)

Biphasic insulin aspart‐30 reduces glycemic variability to a greater degree than insulin detemir: A randomized controlled trial of once‐daily insulin regimens using continuous glucose monitoring
por: Tsujino, Daisuke, et al.
Publicado: (2017)

24-Hour Glycemic Variations in Drug-Naïve Patients with Type 2 Diabetes: A Continuous Glucose Monitoring (CGM)-Based Study
por: Ando, Kiyotaka, et al.
Publicado: (2013)

Is it possible to predict the onset of nocturnal asymptomatic hypoglycemia in patients with type 1 diabetes receiving insulin degludec? Potential role of previous day and next morning glucose values
por: Takahashi, Hiroshi, et al.
Publicado: (2020)

Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): Crossover pilot study (J-VICTORIA study)
por: Sakamoto, Masaya, et al.
Publicado: (2012)

Hypoglycemia Unawareness in Insulinoma Revealed with Flash Glucose Monitoring Systems
por: Sugawa, Taku, et al.
Publicado: (2018)

Population‐based cross‐sectional study on insulin resistance and insulin‐secretory capacity in Japanese school children
por: Nishimura, Rimei, et al.
Publicado: (2017)

Which is better, high‐dose metformin monotherapy or low‐dose metformin/linagliptin combination therapy, in improving glycemic variability in type 2 diabetes patients with insufficient glycemic control despite low‐dose metformin monotherapy? A randomized, cross‐over, continuous glucose monitoring‐based pilot study
por: Takahashi, Hiroshi, et al.
Publicado: (2018)

Continuous glucose monitoring in a patient with insulinoma presenting with unawareness of postprandial hypoglycemia
por: Nakajima, Rikako, et al.
Publicado: (2023)

A New Role for Hypothalamic Glucose-Sensing Neurons in Hypoglycemia Unawareness
por: Fioramonti, Xavier
Publicado: (2023)

Effect of Hemodialysis on Plasma Glucose Profile and Plasma Level of Liraglutide in Patients with Type 2 Diabetes Mellitus and End-Stage Renal Disease: A Pilot Study
por: Osonoi, Takeshi, et al.
Publicado: (2014)

Major Increases between Pre- and Post-breakfast Glucose Levels May Predict Nocturnal Hypoglycemia in Type 2 Diabetes
por: Takeishi, Soichi, et al.
Publicado: (2016)

Real-Time Continuous Glucose Monitoring Significantly Reduces Severe Hypoglycemia in Hypoglycemia-Unaware Patients With Type 1 Diabetes
por: Choudhary, Pratik, et al.
Publicado: (2013)

Age at Transition from Pediatric to Adult Care Has No Relationship with Mortality for Childhood-Onset Type 1 Diabetes in Japan: Diabetes Epidemiology Research International (DERI) Mortality Study
por: Onda, Yoshiko, et al.
Publicado: (2016)

Improving Epinephrine Responses in Hypoglycemia Unawareness With Real-Time Continuous Glucose Monitoring in Adolescents With Type 1 Diabetes
por: Ly, Trang T., et al.
Publicado: (2011)

Hypoglycemia unawareness identified by continuous glucose monitoring system is frequent in outpatients with type 2 diabetes without receiving intensive therapeutic interventions
por: Huang, Bingkun, et al.
Publicado: (2022)

Effects of dulaglutide combined with insulin degludec on glucose fluctuations and appetite in type 2 diabetes
por: Huang, Jinxin, et al.
Publicado: (2023)

Diagnosis and Treatment Course of Insulinoma Presenting as Hypoglycemia Unawareness Using a Factory-Calibrated Continuous Glucose Monitoring System
por: Aida, Azusa, et al.
Publicado: (2022)

Hypoglycemia-Associated Autonomic Failure in Type 1 Diabetes: Beyond Hypoglycemia Unawareness
por: Giannakopoulos, Aristeidis, et al.
Publicado: (2022)

Factors associated with hypoglycemia unawareness and severe hypoglycemia in type 1 diabetes mellitus patients
por: Takagi, Satoshi, et al.
Publicado: (2022)

Commentary to “Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec” by Kawaguchi et al. Diabetes Therapy 2019
por: Pieber, Thomas R., et al.
Publicado: (2020)

Value of Capillary Glucose Profiles in Assessing Risk of Nocturnal Hypoglycemia in Type 1 Diabetes Based on Continuous Glucose Monitoring
por: Ling, Qing, et al.
Publicado: (2020)

Asprosin response in hypoglycemia is not related to hypoglycemia unawareness but rather to insulin resistance in type 1 diabetes
por: Groener, Jan Benedikt, et al.
Publicado: (2019)

Continuous glucose monitoring with Humalog Mix 25 versus Humalog Mix 50, twice daily: A comparative pilot study -Results from the Jikei-EValuation of insulin Lispro mixture on pharmacodynamics and glycemic VariancE (J-EVOLVE) study
por: Nishimura, Rimei, et al.
Publicado: (2010)

Non-Alcoholic Fatty Liver Disease Markers Associated with Fasting Serum Insulin and Urinary Albumin Excretion Independent of Fasting Plasma Glucose
por: Katoh, Shuichi, et al.
Publicado: (2020)

SUN-179 Prolonged Hypoglycemia from Insulin Degludec
por: Kothari, Vallari, et al.
Publicado: (2019)

Persistent Hypoglycemia Induced by Long-acting Insulin Degludec
por: Katakura, Yukino, et al.
Publicado: (2021)

Hypoglycemia Unawareness in Older Compared With Middle-Aged Patients With Type 2 Diabetes
por: Bremer, Jan P., et al.
Publicado: (2009)

Hypoglycemia unawareness and autonomic dysfunction in diabetes: Lessons learned and roles of diabetes technologies
por: Lin, Yu Kuei, et al.
Publicado: (2020)

Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis
por: Buckingham, Bruce A., et al.
Publicado: (2015)

Seasonal Variation in Severe Glucose-lowering Drug-induced Hypoglycemia in Patients with Type 2 Diabetes
por: Minamoto-Higashioka, Mayu, et al.
Publicado: (2019)

GREATER HYPOGLYCEMIA UNAWARENESS IN OLDER COMPARED TO YOUNGER RURAL VETERANS WITH TYPE 2 DIABETES
por: Valencia, Willy Marcos, et al.
Publicado: (2019)

Persistent Postgastrectomy Hypoglycemia Unawareness in Patients With Gastric Cancer Unveiled by a Prospective Study
por: Kubota, Takeshi, et al.
Publicado: (2022)

Effect of the FreeStyle Libre™ flash glucose monitoring system on glycemic control in individuals with type 2 diabetes treated with basal–bolus insulin therapy: An open label, prospective, multicenter trial in Japan
por: Ogawa, Wataru, et al.
Publicado: (2020)

Nocturnal Glucose Patterns with and without Hypoglycemia in People with Type 1 Diabetes Managed with Multiple Daily Insulin Injections
por: Kladov, Danil E., et al.
Publicado: (2023)

Glucose-Lowering Effect of Insulin Degludec is Independent of Subcutaneous Injection Region
por: Nosek, Leszek, et al.
Publicado: (2014)

Comment on Harlan. Islet Transplantation for Hypoglycemia Unawareness/Severe Hypoglycemia: Caveat Emptor. Diabetes Care 2016;39:1072–1074
por: Hering, Bernhard J., et al.
Publicado: (2017)

Prolonged Nocturnal Hypoglycemia Is Common During 12 Months of Continuous Glucose Monitoring in Children and Adults With Type 1 Diabetes
Publicado: (2010)

A Case of Persistent Hyperinsulinemic Hypoglycemia of Infancy Successfully Managed with Subcutaneous Octreotide Injection and Nocturnal Intravenous Glucose Supply
por: Murakami, Mari, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_5hif3428e4mv0m28ofgboi5e9r